All research
2026-06-11 PubMed

Lachnospiraceae strains alleviate IBS symptoms in mice via distinct gut-brain axis modulation

Therapeutic potential of Lachnospiraceae strains in irritable bowel syndrome via differential gut-brain pathways.

Background

Irritable bowel syndrome (IBS) is a highly prevalent and debilitating disorder with limited effective treatments. Current approaches often target bowel dysfunction or central neuromodulators, but a significant gap remains in understanding the precise role of specific gut microbiota. Prior research linked the Lachnospiraceae family to IBS severity, yet conflicting data necessitated a deeper investigation into the heterogeneous mechanisms by which individual strains within this family might influence the gut-brain axis, visceral hypersensitivity, and intestinal barrier function.

Study Design

Researchers evaluated four representative Lachnospiraceae strains in IBS mice with a standardized gut microbiota baseline (SynCom-23). Core IBS symptoms were assessed via body weight, fecal status, and visceral hypersensitivity. Intestinal inflammation, oxidative stress, and barrier function were quantified using ELISA and RT-qPCR. Gut microbiota and metabolites were analyzed by 16S rRNA sequencing, GC-FID, and LC-MS, alongside brain neurotransmitter systems. The study compared the effects of individual strains and a combined strain approach against control groups.

Results

All four Lachnospiraceae strains effectively alleviated IBS symptoms in mice. They significantly reduced weight loss (P < 0.001) and markers of visceral hypersensitivity, specifically calcitonin gene-related peptide (CGRP) and transient receptor potential vanilloid 1 (TRPV1) (P < 0.0001). Each strain demonstrated distinct mechanistic pathways:

Blautia wexlerae MW-022 produced substantial acetic acid, stimulated Lactobacillaceae proliferation, and targeted the γ-aminobutyric acid/glutamate (GABA/Glu) system. Roseburia faecis MW-024 primarily produced butyrate, also affecting the GABA/Glu system. Dorea longicatena MW-023 enhanced the serotonin (5-HT) system at both synthesis and reception levels, while Coprococcus eutactus DSM107541 modulated the 5-HT system via a "clearance-reception" mode. Combined strains achieved more comprehensive gut micro-ecology restoration, suggesting synergistic effects.

Key Findings

  • All four Lachnospiraceae strains alleviated IBS symptoms in mice, reducing weight loss (P < 001).
  • Visceral hypersensitivity markers CGRP and TRPV1 were significantly reduced (P < 0001) by the strains.
  • Blautia wexlerae MW-022 modulated the GABA/Glu system and stimulated Lactobacillaceae proliferation.
  • Roseburia faecis MW-024 produced butyrate and also affected the GABA/Glu system.
  • Dorea longicatena MW-023 and Coprococcus eutactus DSM107541 differentially modulated the serotonin (5-HT) system.

Why It Matters

This study offers a foundational understanding of how specific gut bacteria can modulate the gut-brain axis to alleviate IBS symptoms, moving beyond broad taxonomic associations to strain-level precision. Understanding these differential mechanisms opens the door for highly personalized probiotic strategies, potentially allowing clinicians or biohackers to select specific Lachnospiraceae strains based on an individual's dominant IBS pathophysiology (e.g., GABAergic vs. serotonergic dysregulation). While preclinical, this work highlights the potential for targeted microbial interventions to address specific aspects of visceral hypersensitivity and gut-brain signaling, paving the way for future human trials and more effective, tailored IBS treatments.


ibs lachnospiraceae gut-brain-axis probiotics visceral-hypersensitivity gaba
Source: pubmed:42272860 · Ingested 2026-06-11 · Digest: gemini-2.5-flash